Thermo Fisher Scientific | TMO - Debt

Stock Price
470.22
Daily Change
2.18 0.47%
Monthly
-2.05%
Yearly
9.99%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $39.39B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Agilent USD 3.35B 55M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.4B 11.2M Sep/2025
Boston Scientific USD 11.44B 610M Dec/2025
Bruker USD 2.01B 426.8M Sep/2025
Charles River Laboratories USD 2.63B 157.4M Sep/2025
Danaher USD 18.48B 66M Mar/2026
Dentsply International USD 2.48B 14M Sep/2025
Edwards Lifesciences USD 600M 105.4M Mar/2026
General Electric Aerospace USD 20.28B 217M Mar/2026
Henry Schein USD 3.44B 83M Sep/2025
Illumina USD 2.58B 22M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Medtronic USD 28.07B 1.03B Dec/2025
Mettler Toledo International USD 2.21B 25.94M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Olympus JPY 233.87B 4.77B Sep/2025
OraSure Technologies USD 782K 465K Jun/2024
Quest Diagnostics USD 6.41B 179M Mar/2026
Repligen USD 542.21M 146.65M Dec/2025
Revvity USD 3.37B 5.86M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Veracyte USD 40.45M 10.19M Sep/2025
Waters USD 1.49B 52.2M Sep/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025